Sage Therapeutics
SAGE
#7064
Rank
NZ$0.91 B
Marketcap
NZ$14.57
Share price
0.00%
Change (1 day)
3.83%
Change (1 year)

Earnings for Sage Therapeutics (SAGE)

Earnings in 2025 (TTM): -NZ$0.51 Billion

According to Sage Therapeutics 's latest financial reports the company's current earnings are NZ$70.41 Million. In 2024 the company made an earning of -NZ$0.68 Billion, an increase over its 2023 earnings that were of -NZ$0.91 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sage Therapeutics from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.51 Billion-24.39%
2024 -NZ$0.68 Billion-26.01%
2023 -NZ$0.91 Billion1.63%
2022 -NZ$0.9 Billion16.36%
2021 -NZ$0.77 Billion-175.55%
2020 NZ$1.01 B-189.1%
2019 -NZ$1.15 Billion82.43%
2018 -NZ$0.63 Billion38.04%
2017 -NZ$0.46 Billion69.9%
2016 -NZ$0.27 Billion68.25%
2015 -NZ$0.16 Billion179.48%
2014 -NZ$56.76 Million84.98%
2013 -NZ$30.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regulus Therapeutics
RGLS
-NZ$79.61 Million-84.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
-NZ$97.37 Million-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
NZ$0.86 B-270.17%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eagle Pharmaceuticals
EGRX
NZ$59.85 M-111.84%๐Ÿ‡บ๐Ÿ‡ธ USA